VAN ANDEL RESEARCH INSTITUTE

The Van Andel Research Institute is a research-focused organization specializing in biomedical science and translational research, with core capabilities centered on molecular biology, genetics, epigenetics, and neurodegenerative disease mechanisms. Their technical expertise includes high-throughput genomic analysis, CRISPR-based gene editing, proteomic profiling, and advanced imaging techniques to uncover disease pathways and identify therapeutic targets. The institute distinguishes itself through its integrated approach to basic and applied research, leveraging proprietary platforms for drug discovery and biomarker validation in collaboration with academic and clinical partners. Their work emphasizes reproducibility, data-driven hypothesis testing, and the translation of laboratory findings into clinically actionable insights. Award history does not indicate specific federal contracts or agency engagements, and no recent award data is available to infer direct government program involvement. Consequently, there is no discernible pattern of work performed for federal agencies, nor evidence of formal procurement relationships with departments such as NIH, DOD, or VA. The primary NAICS code 541715 classifies the organization within Research and Development in the Physical, Engineering, and Life Sciences. In practice, this reflects non-clinical, discovery-stage research in life sciences, positioning the institute as a knowledge-driven entity focused on advancing scientific understanding rather than delivering commercial IT or defense systems. Their market presence is anchored in academic and nonprofit research ecosystems, with limited evidence of direct government contracting activity. The Van Andel Research Institute operates as a nonprofit research entity based in Grand Rapids, Michigan, with no publicly disclosed government certifications such as 8(a), HUBZone, or SDVOSB. Its scale and structure are aligned with institutional research missions rather than commercial contracting, and its geographic footprint remains localized to its primary campus, with no indication of federal market expansion beyond its research collaborations.